| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,802 |
32,810 |
$2.07M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,630 |
18,804 |
$783K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,078 |
2,548 |
$174K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,542 |
2,295 |
$157K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,238 |
4,202 |
$140K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,930 |
6,259 |
$87K |
| 87430 |
|
8,923 |
7,956 |
$83K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,370 |
1,272 |
$81K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,748 |
7,441 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,173 |
8,952 |
$56K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,995 |
3,731 |
$49K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
596 |
535 |
$46K |
| 87428 |
|
2,101 |
1,875 |
$44K |
| 87807 |
|
4,184 |
3,396 |
$38K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,794 |
1,572 |
$38K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
364 |
329 |
$24K |
| 92587 |
|
1,550 |
1,346 |
$20K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
644 |
591 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,483 |
4,785 |
$13K |
| 80305 |
|
1,842 |
1,381 |
$11K |
| 81002 |
|
6,223 |
5,306 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
133 |
116 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,453 |
3,086 |
$4K |
| 86308 |
|
560 |
511 |
$2K |
| 96127 |
|
3,045 |
2,011 |
$2K |
| 90474 |
|
250 |
231 |
$2K |
| 99173 |
|
1,345 |
1,228 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
51 |
47 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
12 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,383 |
3,001 |
$958.24 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
762 |
654 |
$820.48 |
| 90686 |
|
823 |
715 |
$684.06 |
| 36416 |
|
11,926 |
9,126 |
$544.98 |
| 83655 |
|
61 |
53 |
$450.21 |
| 90620 |
|
17 |
14 |
$320.00 |
| 99188 |
|
16 |
16 |
$288.60 |
| 94760 |
|
991 |
789 |
$165.02 |
| 96160 |
|
85 |
58 |
$110.00 |
| 88720 |
|
66 |
25 |
$102.82 |
| 90648 |
|
369 |
354 |
$0.00 |
| 90670 |
|
688 |
638 |
$0.00 |
| 90633 |
|
203 |
180 |
$0.00 |
| 90710 |
|
29 |
28 |
$0.00 |
| 90671 |
|
322 |
289 |
$0.00 |
| 90681 |
|
73 |
70 |
$0.00 |
| 90723 |
|
116 |
111 |
$0.00 |
| 90697 |
|
419 |
369 |
$0.00 |
| 90680 |
|
169 |
161 |
$0.00 |
| 90677 |
|
119 |
103 |
$0.00 |
| 90688 |
|
33 |
30 |
$0.00 |